SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD.

(1349)
  Rapport
Vertraagde tijd Hong Kong Stock Exchange  -  10:08 24-06-2022
3.400 HKD   +1.49%
08/06Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Ontvangt het bericht van aanvaarding van het Nationaal Beheer Medische Producten van de Volksrepubliek China
CI
29/04Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Maakt winstcijfers bekend voor het eerste kwartaal eindigend op 31 maart 2022
CI
28/03Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Stelt slotdividend voor het op 31 december 2021 geëindigde jaar voor, betaalbaar op 26 augustus 2022
CI
OverzichtKoersenGrafiekenNieuwsAgendaOndernemingFinanciŽnBeursproducten 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD.
19/06Certain A Shares of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. are subject ..
08/06Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Receives the Acceptance Notice Is..
29/04Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Reports Earnings Results for the ..
28/03Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Proposes Final Dividend for the Y..
25/02Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2021US FDA Accepts Fudan-Zhangjiang Bio's Clinical Trial Application for Port Wine Stain Dr..
2021Fudan-Zhangjiang Bio Arm Enrolls First Patient in Clinical Trial of Generic Primary Bil..
2021Chinese Regulators Approve Clinical Trial of Fudan-Zhangjiang Bio for Ulcerative Coliti..
2021China Accepts Fudan-Zhangjiang Bio's Clinical Trial Application for Dermatitis Treatmen..
2021Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Receives the Acceptance Notice b..
2021Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Appoints Huang Jian as Chairman ..
2021Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2021SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Chinese Regulators Accept Shanghai Fudan-Zhangjiang..
2021Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Receives Acceptance Notice Issue..
2021Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Announces Resignation of Tang Yu..
2021SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMA : 688505) added to S&P Global BMI Index
2021SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Interim results announcement for the six months end..
2021Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2021Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. commences an Equity Buyback Plan..
2021SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMA : 688505) added to Shanghai Stock Exchange Composite ..
2021SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMA : 688505) added to Shanghai Stock Exchange A Share In..
2021Certain A Shares of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. are subject ..
2021SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Supplemental circular
2021SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Zhangjiang Swings to Profit in Q1 as Revenue Balloo..
2021Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2021SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Chinese Regulators Accept Fudan-Zhangjiang Bio's Cl..
2021SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Chinese Regulators Accept Fudan-Zhangjiang Bio's Cl..
2021SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Indicative announcement-fda018 antibody drug conjug..
2021Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Receives Acceptance Notice for t..
2021SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Circular
2021SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Proxy form for class meeting of holders of h shares
2021SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : (1) proposed adoption of the 2021 restricted incent..
2021SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Zhangjiang Books Lower Profit, Revenue in 2020; Sha..
2021SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Fudan-Zhangjiang Bio to Acquire Nearly 40% Stake in..
2021SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Discloseable transaction-acquisition of equity inte..
2021Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2021SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Adjustments in the roles of members of the nominati..
2021SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Utilisation of part of the over subscription procee..
2021Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Announces Nomination Committee C..
2021Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Recommends Final Dividend for th..
2021SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Inside information-proposed grant of general mandat..
2021Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. entered into equity transfer agr..
2021Shanghai Handu Pharmaceutical Technology Co., Limited announced that it expects to rece..
2021SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Fudan-Zhangjiang Bio Unit Wins Marketing Approval i..
2021SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Inside information - announcement of preliminary an..
2021SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Indicative announcement on obtaining drug registrat..
2020Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2020SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Interim Report For the Six Months Ended 30 June 202..
2020Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2020Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2020Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Approves Election of Tang Yu Kua..
2020Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2020SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Circular
2020Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Proposes Dividend for the Year E..
2020Shenyang Rongke Rongtuo Health Data Industry Equity Investment Partnership (Limited Par..
2020SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Articles of association
2020SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Poll results of extraordinary general meeting, clas..
2020SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Voluntary announcement-precautions during the epide..
2020Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Announces Earnings Guidance for ..
2019Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. Reports Earnings Results for the ..
2019SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Inside information-unaudited consolidated financial..
2019SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Poll results of extraordinary general meeting
2019SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Further announcement on suspension of review by the..
2019SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Announcement on suspension of review by the listing..
2019SHANGHAI FUDAN ZHANGJIANG BIO PHARMA : Continuing connected transactions-sales and distrib..
2019SHANGHAI FUDAN ZHANGJIANG BIO PHARM : Extraordinary general meeting reply slip
2019SHANGHAI FUDAN ZHANGJIANG BIO PHARM : Proxy form for extraordinary general meeting
2019SHANGHAI FUDAN ZHANGJIANG BIO PHARM : Continuing connected transactions-sales and distribu..
2019Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Signs Sales and Distribution Agr..
2019SHANGHAI FUDAN ZHANGJIANG BIO PHARM : Announcement on resumption of the review process of ..
2019SHANGHAI FUDAN ZHANGJIANG BIO PHARM : Interim Report For the Six Months Ended 30 June 2019
2019Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Reports Earnings Results for the..
2019Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Provides Earnings Guidance for t..
2019Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. entered into state-owned equity ..
2019Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Proposes Appointment of Members ..
1  2Volgende
Volgende evenement op SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD.